
Aditxt Terminates Acquisition Agreement with Appili Therapeutics
Aditxt Inc. has decided to end its planned acquisition of Appili Therapeutics due to lack of strategic alignment, marking a significant shift in the company's expansion strategy. The termination highlights the complexities of corporate mergers and acquisitions in the health innovation sector.
Read full story

















